Compare Heron Therapeutics Inc (HRTX) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Jones Lang LaSalle Inc — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Jones Lang LaSalle Inc trades at $325.29 (market cap $15.12B). The key difference: Jones Lang LaSalle Inc is far larger — about 165.3× Heron Therapeutics Inc's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | JLL | |
|---|---|---|
Market Cap | $91.46M | $15.12B |
Sector | Health | Real Estate |
52-Week High | $1.96 | $358.66 |
52-Week Low | $0.39 | $253.48 |
Enterprise Value | $189.36M | $18.66B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
